Hikma Pharmaceuticals

Xellia Pharmaceuticals ApS is a specialty pharmaceutical company headquartered in Copenhagen, Denmark, with additional facilities in Budapest, Hungary; Taizhou, China; and Raleigh, North Carolina. Founded in 1959, Xellia focuses on the development, manufacture, and supply of anti-infective products, specifically targeting serious bacterial and antibiotic-resistant infections, as well as certain fungal diseases. The company is recognized as a leading supplier of fermented and semi-synthetic active pharmaceutical ingredients (APIs) and finished dosage forms (FDF), with a particular emphasis on its flagship products, Vancomycin and Colistimethate Sodium. Xellia serves over 700 customers in more than 70 countries and offers a range of services, including antibiotic contract manufacturing, custom synthesis for clinical trials, and the development of innovative delivery systems for injectable, topical, and inhaled administration. The company's manufacturing facilities adhere to current Good Manufacturing Practice (cGMP) standards and are approved by relevant regulatory authorities, including the US Food and Drug Administration. With a workforce of over 850 employees, Xellia is committed to expanding its product offerings to meet evolving treatment needs.

Rakuten Medical, Inc. is a clinical-stage biotechnology company focused on developing precision-targeted therapies for cancer treatment. Founded in 2010 and headquartered in San Mateo, California, the company also has offices in Tokyo, Taiwan, Amsterdam, and Sinn-Fleisbach. Rakuten Medical is known for its proprietary Alluminox platform, which combines investigational drugs, devices, and other components to create cell-targeting therapies. Among its notable products are ASP-1929, an antibody-drug conjugate combining cetuximab and IRDye 700DX, and RM-1929, which employs photoimmunotherapy specifically for treating head and neck cancer. The firm aims to advance innovative treatment options that enhance the precision and effectiveness of cancer therapies.

CUSTOpharm is a service-oriented company that specializes in providing personalized and cost-effective chemistry and manufacturing controls (CMC) and regulatory support for businesses with limited resources or those looking to expand. The company has a strong foundation in product development, having created 54 sterile products, including 48 injectable products, alongside nasal, oral, and sterile ophthalmic formulations. CUSTOpharm excels in sourcing difficult-to-obtain raw materials and addressing formulation and analytical challenges. With a notable history in regulatory affairs, it pioneered the first electronic Common Technical Document (eCTD) Abbreviated New Drug Application (ANDA) submission to the FDA in 2004 and has since filed over 170 ANDAs. This extensive experience enables CUSTOpharm to maintain a comprehensive perspective on clients' projects, focusing on delivering marketable finished products rather than merely completing individual tasks.

EIMC United Pharma, a pharmaceutical manufacturing company, specializes in manufacturing oncology generics.

Roxane Laboratories, Inc. is a specialty generics company based in Columbus, Ohio, founded in 1885. It focuses on the research, development, manufacture, marketing, sale, and distribution of generic pharmaceuticals in the United States. Roxane Laboratories offers a diverse portfolio of 111 products across seven dosage forms, including immediate-release solids, nasal sprays, liquids, and sublingual tablets. The company's key marketed products include fluticasone, buprenorphine, methotrexate, prednisone, and calcium acetate. Additionally, Roxane has an extensive pipeline of approximately 90 products in various stages of development and manufactures branded pharmaceutical products. The company serves wholesalers, retail chain pharmacies, and group purchasing organizations. Roxane Laboratories was previously known as Philips Roxane until its name change in 1978 and currently operates as a subsidiary of Eurohealth (U.S.A.), Inc.

Bedford Laboratories engages in the manufacture and distribution of generic injectables.

Egyptian Company for Pharmaceuticals & Chemical Industries manufacture pharmaceutical products. The company’s products include cephalosporin anti–infective medicines.

Promopharm SA is an industrial pharmaceutical company that specializes in the production, marketing, import, and export of a wide range of pharmaceutical and parapharmaceutical products. The company focuses on dermo-pharmaceuticals and cosmetics, serving various markets with its diverse product offerings. Its operations encompass both local and international trade, ensuring a comprehensive presence in the pharmaceutical industry.

Unimark Remedies is a healthcare company that specializes in the development and manufacturing of generic medicines across a range of therapeutic areas, including respiratory, cardiovascular, anti-infective, and central nervous system disorders. The company aims to serve clients and customers globally by providing affordable generic formulations. In addition to its core offerings of generic medicines, Unimark Remedies also produces a variety of healthcare products, which include diagnostics, medical devices, finished formulations, cosmeceuticals, animal healthcare products, and active pharmaceutical ingredients. Through its diverse portfolio, Unimark Remedies strives to establish a strong presence in the global pharmaceutical market.

The Arab Pharmaceutical Manufacturing Co. Ltd. manufactures pharmaceutical products.

Alkan Pharma is develops and manufactures generic pharmaceuticals in both solid and liquid forms.

Thymoorgan Pharmazie GmbH produces thymus extracts and various organ extracts; and manufactures liquid and freeze-dried parenterals.

Jazeera Pharmaceuticals Industries is engages in the research, development, manufacture, and marketing of pharmaceutical products. It provides pharmaceutical products in tablet, syrup, and cream forms for applications in musculoskeletal, anti-infective, cardiovascular, CNS, respiratory, dermatology, alimentary, and genito-urinary therapeutic areas.